INTERNATIONAL PATENT: AKSTON BIOSCIENCES CORPORATION FILES APPLICATION FOR "NGF ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE"

GENEVA, April 29 -- AKSTON BIOSCIENCES CORPORATION (100 Cummings Center, Ste 454CBeverly, Massachusetts 01915) filed a patent application (PCT/US2025/051029) for "NGF ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE" on Oct 15, 2025. With publication no. WO/2026/085185, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZION, Todd C. (16 Winter StreetSalem, Massachusetts 01970), LANCASTER, Thomas M. (166 Larch RowWenham, Massachusetts 01984)

Abstract: The present disclosure provides recombinantly...